US 2008/0269296 A1 · DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS

Diaryl ethers as opioid receptor antagonists

AssigneeEli Lilly and Company

InventorsMaria-Jesus Blanco-Pillado, Mark Donald Chappell, Marta Garcia De La Torre, Nuria Diaz Buezo, James Erwin Fritz, William Glen Holloway, James Edward Matt, Charles Howard Mitch, Concepcion Pedregal-Tercero, Steven James Quimby, Miles Goodman Siegel, Dana Rae Smith, Russell Dean Stucky, Kumiko Takeuchi, Elizabeth Marie Thomas, Chad Nolan Wolfe

Life of this patent

Estimating the term…

Abstract

A compound of the formula (I) wherein the variables X1 to X10, R1 to R7 including R3′, E, v, y, z. A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed.

Claims3

Dependent claims

1-41. (canceled)

Dependencies are inferred from the claim text.

Facts

Application

12/052,972Filed 21 Mar 2008

Priority

19 Sep 2002

Published

30 Oct 2008

Term ends

Not estimatedThe source records don’t support an estimate.

Classification43 codes

C07D 213/643
Attached in position 2 or 6: 2-Phenoxypyridines; Derivatives thereof
A61P 1/08
Drugs for disorders of the alimentary tract or the digestive system: for nausea, cinetosis or vertigo; Antiemetics
A61P 1/12
Drugs for disorders of the alimentary tract or the digestive system: antidiarrhoeals
A61P 3/00
Drugs for disorders of the metabolism

Family

Application60/412,158Us provisional application · filed 19 Sep 2002

Application10/526,960Continuation · filed 3 Mar 2005

Application12/052,972Continuation

US 2006/0217372 A1Published application

US 7,381,719 B2Related patent

US 7,531,557 B2Related patent

US 2008/0269296 A1This patent

From the US filing history. Foreign family members aren’t listed.